Patents-Review.com
🔗 Permalink
Inventor profile of:

Peter Kufer

City:

Moosburg

Country:

Germany

Published Applications:

26

Last publication date:

2023-11-09

Top Assignees for applications by Peter Kufer

The entities that hold a legal rights for patent applications filed by inventor Kufer Peter:

Recent patent applications by Kufer Peter

Peter Kufer from Moosburg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-09
US20230357444A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

 #2 | 2016-07-21
US20160208338A1
Chemistry; metallurgy

Method of Treating a Patient or Exempting a Patient From Further Treatment Subsequent to Tumor Removal

 #3 | 2014-07-22
US10554731
-

Human-anti-human cd3 binding molecules

 #4 | 2013-10-17
US20130273050A1
Chemistry; metallurgy

Pharmaceutical compositions with resistance to soluble CEA

 #5 | 2013-05-23
US20130129729A1
Human necessities

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF

 #6 | 2013-04-18
US20130095103A1
Human necessities

Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemia

 #7 | 2012-09-27
US20120244162A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

 #8 | 2012-05-17
US20120121600A1
Chemistry; metallurgy

Pharmaceutical antibody compositions with resistance to soluble CEA

 #9 | 2011-10-20
US20110256137A1
Chemistry; metallurgy

Pharmaceutical composition comprising a bispecific antibody for EpCAM

 #10 | 2010-07-22
US20100183615A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

 #11 | 2010-06-17
US20100150918A1
Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

 #12 | 2009-11-26
US20090291072A1
Human necessities

Means and methods for the treatment of tumorous diseases

 #13 | 2009-10-08
US20090252683A1
Human necessities

Composition comprising cross-species-specific antibodies and uses thereof

 #14 | 2009-09-24
US20090241202A1
Chemistry; metallurgy

DOMAIN-GRAFTED ANTIBODIES

 #15 | 2009-09-10
US20090226444A1
Chemistry; metallurgy

PHARMACEUTICAL ANTIBODY COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA

 #16 | 2009-09-10
US20090226432A1
Chemistry; metallurgy

Pharmaceutical compositions with resistance to soluble CEA

 #17 | 2009-03-26
US20090081191A1
Chemistry; metallurgy

Antibodies that bind human 17-A1/EpCAM tumor antigen

 #18 | 2008-10-14
US9554465
-

Method of identifying binding site domains that retain the capacity of binding to an epitope

 #19 | 2008-09-04
US20080213256A1
Chemistry; metallurgy

Less immunogenic binding molecules

 #20 | 2008-02-21
US20080044413A1
Chemistry; metallurgy

EphA2 BiTE molecules and uses thereof

 #21 | 2007-06-05
US9403107
-

Human antibodies that bind human 17-A1/EpCAM tumor antigen

 #22 | 2007-05-31
US20070123479A1
Chemistry; metallurgy

Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders

 #23 | 2007-04-12
US20070081993A1
Chemistry; metallurgy

Pharmaceutical composition comprising a bispecific antibody for EpCAM

 #24 | 2006-09-26
US9673735
-

CD 19×CD3 specific polypeptides and uses thereof

 #25 | 2006-08-31
US20060193852A1
Chemistry; metallurgy

CD19xCD3 specific polypeptides and uses thereof

 #26 | 2006-07-06
US20060147928A1
Chemistry; metallurgy

Real-time RT-PCR for the sensitive detection of multiple MAGE gene transcripts
InventorID:

196675 ⎘